NDN
Necdin
Also known as: HsT16328, NECD_HUMAN, PWCR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99608
- Gene
- NDN
- Ensembl
- ENSG00000182636
- Chromosome
- 15
- Canonical length
- 321 aa
- Protein class
- Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This intronless gene is located in the Prader-Willi syndrome deletion region. It is an imprinted gene and is expressed exclusively from the paternal allele. Studies in mouse suggest that the protein encoded by this gene may suppress growth in postmitotic neurons. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
321 residues, UniProt reviewed canonical sequence.
>Q99608|NDN
1 MSEQSKDLSD PNFAAEAPNS EVHSSPGVSE GVPPSATLAE PQSPPLGPTA APQAAPPPQA
61 PNDEGDPKAL QQAAEEGRAH QAPSAAQPGP APPAPAQLVQ KAHELMWYVL VKDQKKMIIW
121 FPDMVKDVIG SYKKWCRSIL RRTSLILARV FGLHLRLTSL HTMEFALVKA LEPEELDRVA
181 LSNRMPMTGL LLMILSLIYV KGRGARESAV WNVLRILGLR PWKKHSTFGD VRKLITEEFV
241 QMNYLKYQRV PYVEPPEYEF FWGSRASREI TKMQIMEFLA RVFKKDPQAW PSRYREALEE
301 ARALREANPT AHYPRSSVSE DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NDN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 90 nTPM
- basal ganglia: 84 nTPM
- cervix: 76 nTPM
- ovary: 64 nTPM
- endometrium: 61 nTPM
- pituitary gland: 54 nTPM
Single-cell type
- other brain neurons: 114 nCPM
- brain inhibitory neurons: 44 nCPM
- oligodendrocytes: 23 nCPM
- oligodendrocyte progenitor cells: 23 nCPM
- ependymal cells: 21 nCPM
- brain excitatory neurons: 21 nCPM
Immune cell
- plasmacytoid DC: 1.5 nTPM
- myeloid DC: 0.8 nTPM
- intermediate monocyte: 0.3 nTPM
- non-classical monocyte: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- NK-cell: 0.1 nTPM
Brain region
- hypothalamus: 167 nTPM
- pons: 75 nTPM
- basal ganglia: 66 nTPM
- midbrain: 64 nTPM
- cerebral cortex: 60 nTPM
- spinal cord: 54 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NDN.
Disease | ImmuneIEDB
Conditions an epitope on NDN was assayed in.
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.67
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon extension
- axonal fasciculation
- central nervous system development
- genomic imprinting
- glial cell migration
- multicellular organismal-level homeostasis
- negative regulation of transcription by RNA polymerase II
- neuron migration
- neurotrophin TRK receptor signaling pathway
- positive regulation of transcription by RNA polymerase II
- post-embryonic development
- respiratory system process
- sensory perception of pain
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NDN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NDN as an antibody target. Whether an autoantibody or antibody against NDN could matter depends on whether native NDN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NDN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NDN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...